Sun Pharmaceutical Industries Share Price

• Overview
• News
• Analysis
• Recos
• Financials
• Forecast
• Technicals
• Peers
• Shareholdings
• MF
• F&O
• Corp Actions
• About
• More
  • MF
  • F&O
  • Corp Actions
  • About
• EnglishEnglishहिन्दीગુજરાતીमराठीবাংলাಕನ್ನಡதமிழ்తెలుగు
  Rank 59 - ET 5002022 ranking

Sun Pharma News & Analysis

Sun Pharma Share Recommendations

Peer Comparison

Sun Pharma Shareholding Pattern

MF Ownership

• ICICI Pru Value Discovery Direct-G

  Equity: Value Oriented

  5

  • 2,112.01

    Amount Invested (in Cr.)

  • 6.45%

    % of AUM

  • 6.59

    % Change (MoM basis)

• Mirae Asset Large Cap Direct-G

  Equity: Large Cap

  4

  • 801.45

    Amount Invested (in Cr.)

  • 2.27%

    % of AUM

  • 0.00

    % Change (MoM basis)

• ICICI Pru India Opportunities Fund Direct-G

  Equity: Thematic

  • 795.29

    Amount Invested (in Cr.)

  • 7.04%

    % of AUM

  • 0.00

    % Change (MoM basis)

Sun Pharma F&O Quote

Corporate Actions

About Sun Pharma

Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 277,998.95 Crore) operating in Pharmaceuticals sector. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2022.For the quarter ended 30-06-2023, the company has reported a Consolidated Total Income of Rs 12,145.28 Crore, up 7.44 % from last quarter Total Income of Rs 11,303.95 Crore and up 12.83 % from last year same quarter Total Income of Rs 10,763.90 Crore. Company has reported net profit after tax of Rs 2,013.04 Crore in latest quarter.The company’s top management includes Mr.Israel Makov, Mr.Dilip S Shanghvi, Dr.Uday Baldota, Mr.Abhay Gandhi, Mr.Kirti Ganorkar, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Dr.Pawan Goenka, Mr.Rama Bijapurkar, Mr.Sudhir V Valia, Mr.Gautam Doshi, Mr.C S Muralidharan, Mr.Sunil R Ajmera. Company has S R B C & Co. LLP as its auditors. As on 30-06-2023, the company has a total of 239.93 Crore shares outstanding. Show More

Industry

Pharma - Indian

Key Indices Listed on

Nifty 50, S&P BSE Sensex, Nifty 100, + 37 more

Address

Sun Pharma Advanced Research Centre (SPARC),Tandalja,Vadodra, Gujarat - 390012

Contact

secretarial@sunpharma.com

http://www.sunpharma.com

More Details

• Chairman's Speech
• Company History
• Directors Report
• Background information
• Company Management
• Listing Information
• Finished Products

Brands

Sun Pharma

Revital

Volini

Pepfiz

Revital Woman

Show More

FAQs about Sun Pharma share

• 1. What is Sun Pharma share price and what are the returns for Sun Pharma share?
  Sun Pharma share price was Rs 1,158.65 as on 29 Sep, 2023, 03:59 PM IST. Sun Pharma share price was up by 2.32% based on previous share price of Rs 1,132.3. Sun Pharma share price trend:

  • Last 1 Month: Sun Pharma share price moved up by 4.23%
  • Last 3 Months: Sun Pharma share price moved up by 13.39%
  • Last 12 Months: Sun Pharma share price moved up 24.49%
  • Last 3 Years: Sun Pharma Share price moved up by 128.91%
• 2. Which are the key peers to Sun Pharma?
  Top 10 Peers for Sun Pharma are Divi's Laboratories Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., Mankind Pharma Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd., Lupin Ltd., Aurobindo Pharma Ltd., Alkem Laboratories Ltd. and Biocon Ltd.
• 3. What is 52 week high/low of Sun Pharma share price?
  In last 52 weeks Sun Pharma share had a high price of Rs 1,169.70 and low price of Rs 892.05
• 4. Who's the owner of Sun Pharma?
  • Promoter holding has not changed in last 9 months and holds 54.48 stake as on 30 Jun 2023
  • Domestic Institutional Investors holding has gone up from 19.47 (30 Sep 2022) to 19.5 (30 Jun 2023)
  • Foreign Institutional Investors holding has gone up from 16.0 (30 Sep 2022) to 16.48 (30 Jun 2023)
  • Other investor holding have gone down from 10.05 (30 Sep 2022) to 9.54 (30 Jun 2023)
• 5. What are the key metrics to analyse Sun Pharma Share Price?
  Sun Pharma share can be quickly analyzed on following metrics:

  • Stock's PE is 32.96
  • Price to Book Ratio of 4.65
  • Dividend Yield of 0.99
  • EPS (trailing 12 month) of Sun Pharma share is 35.16
• 6. What is the market cap of Sun Pharma?
  Market Capitalization of Sun Pharma stock is Rs 2,77,999 Cr.